跳至主要内容
临床试验/NCT02112136
NCT02112136已完成不适用

Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in Autosomal Dominant Polycystic Kidney Disease (ADPKD): The GeneQuest Study

University Hospital, Brest25 个研究点 分布在 1 个国家目标入组 1,450 人开始时间: 2014年12月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1,450
试验地点
25
主要终点
Number of patients/families with no mutations identified in PKD1 and PKD2 genes

研究概览

简要总结

The aim of this study is to identify families with ADPKD , characterize the phenotype and screen for mutations in known genes (PKD1 and PKD2, and then HNF1b and UMOD in PKD1 PKD2 negative carriers).

Genome wide analysis will be performed in families without mutations identified.

详细描述

  • Inclusion of ADPKD patients in 20 different centers of Nephrology in the Western part of France
  • Characterization of the Phenotype
  • Collect DNA sample
  • Analysis of PKD1 and PKD2 genes first
  • Analysis of HNFIb and UMOD for PKD1 and PKD2 negative patients
  • Recruitment of affected and non-affected relatives of PKD1 and PKD2 negative ADPKD patients
  • Identify new genes involved in ADPKD using exome sequencing in PKD1 and PKD2 negative pedigrees

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •for the proband :
  • •Patients with a diagnosis of ADPKD
  • •Written Informed Consent
  • •Affiliated or benefiting from a national insurance
  • •Inclusion Criteria of the relatives (affected or non affected) :
  • •Relatives with a diagnosis of ADPKD (ADPKD relatives)
  • •And Relatives over age 30 for whom the diagnosis of ADPKD has been discarded (non ADPKD relatives) with renal ultrasonography performed after age
  • •Written Informed consent
  • •Affiliated or benefiting from a national insurance

排除标准

  • •for the Probands:
  • •Subjects unable to provide written informed consent
  • •Previous Molecular analysis of PKD1 and PKD2 genes with identification of the pathogenic mutation
  • •Exclusion criteria for the Relatives:
  • •Subjects unable to provide written informed consent
  • •Age under 30 for the "non-affected" relatives

研究组 & 干预措施

GeneQuest

Other
  • No drug will be administrated in this study
  • Blood collection

干预措施: Blood Collection (Other)

结局指标

主要结局

Number of patients/families with no mutations identified in PKD1 and PKD2 genes

时间窗: 3 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (25)

Loading locations...

相似试验